.Nature Medication, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin resulted in strengthened progression-free and overall survival, bring about FDA approval and a new procedure option for individuals.